Cite
HARVARD Citation
Rostami, I. et al. (2016). Peptide-conjugated PEGylated PAMAM as a highly affinitive nanocarrier towards HER2-overexpressing cancer cells. RSC advances. 6 (109), pp. 107337-107343. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rostami, I. et al. (2016). Peptide-conjugated PEGylated PAMAM as a highly affinitive nanocarrier towards HER2-overexpressing cancer cells. RSC advances. 6 (109), pp. 107337-107343. [Online].